The PSA Test and Prostate Screening: Weighing the Trade-offs

If you're a man in your fifties or sixties living in Pattaya — or flying in for a check-up between countries — sooner or later someone will offer you a PSA test, usually as a single tick-box on a "men's health" panel. It sounds simple: one blood draw to screen for prostate cancer. The honest truth is that PSA is one of the more genuinely debated tests in medicine, and the right answer isn't "always yes." This guide explains what PSA measures, what a raised result does and doesn't mean, and how to weigh the real benefits against the real harms — so you and a doctor can choose together. It's general education, not a diagnosis.

What is PSA, and what does it measure?

PSA stands for prostate-specific antigen — a protein made by the prostate, the small gland that sits below the bladder in men. A little PSA naturally leaks into the blood, and a blood test can measure how much. A raised PSA can be an early flag for prostate cancer, because cancerous tissue tends to release more of it. Crucially, though, a high PSA is not proof of cancer — it's a signal that something is raising the level, and many of those somethings are completely harmless ³.

There's no single PSA number that is universally "normal." Around 4 ng/mL is a commonly used reference point above which doctors look harder, but a level on its own is not diagnostic of cancer — men with low PSA can still have it, and men with high PSA often don't ³. That's why the number is always read in context: your age, your trend over time, and a talk with your doctor.

Why a high PSA often isn't cancer

This is the part most men are never told clearly. PSA rises for plenty of reasons that have nothing to do with cancer. The most common is simply an enlarged prostate — benign prostatic hyperplasia, or BPH — a near-universal part of ageing in which the gland gradually grows and naturally pushes more PSA into the blood ⁴³. Prostatitis (inflammation or infection of the prostate) raises it too, as can ordinary things in the days before the test: recent ejaculation, a long bike ride, a rectal examination, or a urinary procedure ³.

That matters because a raised result is common and frequently a false alarm. About 6–7% of men have a false-positive PSA on any single round of screening ². And of the men who go on to a prostate biopsy because of an elevated PSA, only about 25% actually have prostate cancer ² — three out of four biopsies triggered by a high PSA come back clear.

What's the actual benefit of screening?

The benefit is real, but worth seeing in proportion. The most widely referenced international analysis — from the US Preventive Services Task Force — estimates that for men aged 55–69, screening may prevent roughly 1 to 2 prostate-cancer deaths per 1,000 men screened over about 13 years, and around 3 fewer cases of cancer spreading (metastatic disease) per 1,000 men ¹. (USPSTF is US guidance, not Thai law — but it's among the most carefully weighed reviews of the evidence, which is why clinics worldwide reference it.)

So the upside is genuine: a small number of men are spared a death or an advanced cancer. The catch is that to get there, many are tested, some get a scare, and a few are treated for a cancer that never would have troubled them — holding both truths at once is the whole point of the decision.

What are the honest harms?

Being fair about the downsides is what turns PSA from a sales pitch into a real choice. There are three to know.

Anxiety from false positives. A raised result usually means weeks of worry and more tests before you learn it was nothing ².

Biopsy risks. Sorting a high PSA out often means a prostate biopsy, which can cause pain, bleeding, and occasionally infection ¹. With three in four biopsies finding no cancer, many of those procedures, in hindsight, weren't needed ².

Overdiagnosis and overtreatment — the big one. Many prostate cancers grow so slowly that they would never have caused symptoms or shortened a man's life. Screening can find these, and once found they're often treated — and the treatment itself, with surgery or radiation, carries a real risk of lasting incontinence and erectile dysfunction ¹². Being treated for a cancer that would never have harmed you is, in a real sense, all harm and no benefit. This is why modern care leans on "active surveillance" — watching low-risk cancers rather than rushing to treat.

What does the guidance actually say?

The most widely referenced international guidance frames PSA as a personal decision, not a default test ¹:

• Men aged 55–69: the decision to screen should be individualised — a shared decision between you and your doctor, after weighing the benefits and harms in your own situation. (This is a "C" recommendation: not "do it," not "don't," but "decide together.")
• Men aged 70 and older: routine PSA screening is not recommended, because at that age the harms outweigh the small benefit for most men (a "D" recommendation).

Your personal risk shifts the conversation — a family history of prostate cancer, or being of African descent, raises your baseline risk and is worth flagging to your doctor. But the headline holds: this is a discussion to have, not a box that gets ticked for you.

What we see at the clinic

A lot of the men we meet in Pattaya arrive expecting PSA to be automatic — "just add it to the panel." We don't do that silently. Before we draw it, we talk through what a raised result would actually lead to, because a PSA test is really a decision to start down a path that can include re-tests, scans, and possibly a biopsy. Some men, once they understand the trade-offs, want the test anyway — a perfectly reasonable choice. Others decide to wait, or to focus first on the symptoms they actually have, which are far more often an enlarged prostate (BPH) than anything sinister. We don't treat prostate cancer here, and anything that needs follow-up goes to a urologist; what we offer is an honest conversation and a baseline, not a reflex test. And if you're really asking about low energy or libido, PSA and testosterone are separate questions that often get tangled together.

Common questions

Should I just get a PSA test to be safe? "To be safe" is the instinct, but PSA isn't that simple. The honest approach is to weigh the small, real benefit against the chance of a false alarm, a biopsy, and overtreatment — and to decide with your doctor rather than reflexively ¹².

My PSA came back high — do I have cancer? Most likely not. A high PSA most often reflects a benign cause such as an enlarged prostate, inflammation, or even recent cycling or ejaculation ³⁴. Only about a quarter of men who proceed to a biopsy for a raised PSA actually have cancer ². It usually means "look closer," not "bad news."

Is there a single normal PSA number? No. Around 4 ng/mL is a common reference point, but it's not a hard line, and a level alone doesn't diagnose or rule out cancer — it's read together with your age and history ³. Labs and methods also vary, so comparing across the same lab over time is more useful than a one-off figure.

I'm 72 and feel fine — should I keep screening? Routine PSA screening generally isn't recommended from age 70, because the small potential benefit is outweighed by the harms for most men in that group ¹. It's still worth discussing with your doctor if you're in unusually good health or have specific risk factors.

Can I prepare for the test to get an accurate reading? Yes — a few simple things can falsely raise PSA, so avoid ejaculation and vigorous cycling for a day or two beforehand, and tell your doctor about any recent urinary procedure or rectal exam ³. Our guide to preparing for blood work covers the practical side.

Key takeaway

PSA is a genuinely useful test in the right hands — but it's a decision, not a default. A raised level is an early flag, not a diagnosis, and it rises for many harmless reasons, so false alarms and unnecessary biopsies are common ²³. The benefit is real but modest, and it sits opposite honest harms: anxiety, biopsy risks, and the overtreatment of cancers that would never have hurt you ¹. That's why the most referenced guidance asks men aged 55–69 to decide together with a doctor, and advises against routine screening from 70 ¹. The right move isn't to grab the test or to avoid it on principle — it's to have the conversation, understand what a result would mean, and choose with your eyes open.